HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nehad M Ayoub Selected Research

Glycated Hemoglobin (Glycosylated Hemoglobin)

1/2020Glycosylated Hemoglobin A1c Is Associated with Anthropometric Measurements and Tumor Characteristics in Breast Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nehad M Ayoub Research Topics

Disease

29Neoplasms (Cancer)
01/2024 - 01/2011
23Breast Neoplasms (Breast Cancer)
01/2022 - 01/2011
2Triple Negative Breast Neoplasms
01/2024 - 01/2019
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2014
2Granulomatous Mastitis
01/2020 - 03/2019
2Carcinogenesis
01/2017 - 01/2015
2Hodgkin Disease (Hodgkin's Disease)
10/2016 - 10/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022
1Cancer Pain
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2020
1Hypercholesterolemia
01/2020
1Exanthema (Rash)
01/2020
1Carcinoma (Carcinomatosis)
01/2020
1Sickle Cell Anemia (Hemoglobin S Disease)
07/2019
1Pain (Aches)
07/2019
1Inflammation (Inflammations)
03/2019
1Abscess
03/2019
1Pathologic Neovascularization
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
11/2018
1Cachexia
04/2017
1Anorexia
04/2017
1Hematologic Neoplasms (Hematological Malignancy)
07/2016
1Atherosclerosis
05/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2016
1Multiple Myeloma
10/2015

Drug/Important Bio-Agent (IBA)

6TocotrienolsIBA
05/2014 - 01/2011
5Hormones (Hormone)IBA
01/2022 - 09/2017
4Estrogen ReceptorsIBA
01/2021 - 09/2017
4oleocanthalIBA
05/2019 - 01/2014
3Phosphotransferases (Kinase)IBA
01/2024 - 01/2015
3Tyrosine Kinase InhibitorsIBA
12/2022 - 02/2019
3CrizotinibIBA
01/2021 - 01/2017
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021 - 01/2015
3Biomarkers (Surrogate Marker)IBA
11/2020 - 01/2016
3Olive OilIBA
02/2019 - 01/2014
2tyrosine receptor (receptor, tyrosine)IBA
01/2024 - 01/2015
2human ERBB2 proteinIBA
01/2022 - 01/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2021
2Messenger RNA (mRNA)IBA
01/2022 - 01/2021
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
2Immunoglobulin M (IgM)IBA
01/2020 - 03/2019
2Lapatinib (GW572016)FDA Link
05/2019 - 02/2019
2ErbB Receptors (EGF Receptor)IBA
02/2019 - 01/2019
2VaccinesIBA
01/2019 - 01/2014
2tremortin (penitrem A)IBA
05/2018 - 01/2013
2MitogensIBA
09/2017 - 09/2013
2Tocopherols (Tocopherol)IBA
01/2014 - 01/2011
2sesaminIBA
01/2013 - 11/2012
1capmatinibIBA
12/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Opioid Analgesics (Opioids)IBA
01/2022
1Angiogenesis InhibitorsIBA
01/2022
1Estrogens (Estrogen)FDA Link
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021
1B7-H1 AntigenIBA
01/2021
1ParaffinIBA
01/2021
1pseurotinIBA
01/2020
1LDL Receptors (LDL Receptor)IBA
01/2020
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2020
14- azido- 7- phenylpyrazolo- (1,5a)- 1,3,5- triazineIBA
07/2019
1Cadherins (E-Cadherin)IBA
05/2019
1Proteins (Proteins, Gene)FDA Link
05/2019
1VimentinIBA
05/2019
1Focal Adhesion Protein-Tyrosine KinasesIBA
02/2019
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
02/2019
1PaxillinIBA
02/2019
1Pyruvaldehyde (Methylglyoxal)IBA
01/2019
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2019
1Lactoylglutathione LyaseIBA
01/2019
1EnzymesIBA
01/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2018
1Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
05/2018
1Phenobarbital (Luminal)FDA Link
09/2017
1TamoxifenFDA LinkGeneric
09/2017
1Brentuximab VedotinIBA
10/2016
1Immunoconjugates (Immunoconjugate)IBA
10/2016
1Alkylating AgentsIBA
10/2016
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
07/2016
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
07/2016
1LDL Lipoproteins (beta Lipoproteins)IBA
05/2016
1Syndecan-1 (Syndecan 1)IBA
10/2015
1araguspongine CIBA
01/2015
1AlkaloidsIBA
01/2015
1xestospongin BIBA
01/2015
1alpha-TocopherolFDA Link
05/2014
1MHC class II transactivator proteinIBA
01/2014
1Interferon-gamma (Interferon, gamma)IBA
01/2014
1invariant chain (Ii-Key)IBA
01/2014
1AntioxidantsIBA
01/2014
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2014
1Antisense OligonucleotidesIBA
01/2014

Therapy/Procedure

17Therapeutics
01/2022 - 01/2011
7Drug Therapy (Chemotherapy)
01/2024 - 01/2014
4Precision Medicine
11/2020 - 10/2015
2Immunotherapy
01/2019 - 01/2014
1Pain Management
07/2019
1Neoadjuvant Therapy
05/2019
1Radiotherapy
01/2019